Clinical Trial

Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis

Name: Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis — clinical trial record (NCT07716332)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to compare the use of oral apixaban to subcutaneous enoxaparin for venous thromboembolism (VTE) prophylaxis in postpartum women at high risk for VTE. The primary goal is to evaluate medication adherence rates and patient satisfaction with the treatment.

Trial Details

NCT Number	NCT07716332
Lead Sponsor	Ron Beloosesky MD
Conditions	Postpartum, DVT Prophylaxis
Enrollment	150 participants
Start Date	2026-07-01
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-21